| Literature DB >> 30602975 |
Martha F Mushi1, Nathaniel Ngeta2, Mariam M Mirambo1, Stephen E Mshana1.
Abstract
Entities:
Mesh:
Year: 2018 PMID: 30602975 PMCID: PMC6306978 DOI: 10.4314/ahs.v18i2.33
Source DB: PubMed Journal: Afr Health Sci ISSN: 1680-6905 Impact factor: 0.927
Risk factors associated with esophageal candidiasis among HIV negative patients attending e ndoscopy unit (n=554)
| Variable | Univariate | Multivariate | |||
| EC n | OR(95%CI) | P | OR(95%CI) | P | |
| 3931–50 | 0.99(0.96–1.02) | 0.365 | 0.95(0.92–0.99) | 0.035 | |
| Male (307) | 11(3.6) | 1 | |||
| Female (247) | 9(3.6) | 1.02(0.414–2.496) | 0.97 | 11.74(1.55–88.82) | 0.017 |
| No (475) | 6(1.3) | 1 | |||
| Yes (79) | 14(17.7) | 16.8(6.25–45.35) | <0.001 | 20.45(4.89–86.56) | <0.001 |
| No (515) | 13(2.5) | 1 | |||
| Yes (39) | 7(18) | 8.45(3.15–22.64) | <0.001 | 5.44(1.18–25.12) | 0.03 |
| No (551) | 18(3.3) | 1 | |||
| Yes (3) | 2(66.7) | 59.2(5.13–683.5) | 0.001 | − | − |
| No (241) | 3(1.2) | 1 | |||
| Yes (313) | 17(5.43) | 4.56(1.32–15.73) | 0.016 | 3.90(0.90–16.85) | 0.068 |
| No (448) | 9(2.01) | 1 | |||
| Yes (106) | 11(10.38) | 5.64(2.27–14.01) | <0.001 | 5.2(1.67–16.21) | 0.005 |
| Negative (542) | 14(2.6) | 1 | |||
| Positive (12) | 6(50.0) | 37.7(10.81–131.62) | <0.001 | − | − |
| No (473) | 13(2.8) | 1 | |||
| Yes (81) | 7(8.6) | 3.35(1.29–8.66) | 0.013 | 8.24(2.21–30.72) | 0.002 |
| No (550) | 18(3.27) | 1 | |||
| Yes (4) | 2(50.0) | 29.56(3.94–221.79) | 0.001 | − | − |
PUD is the peptic ulcer diseases; some known variable like use of corticosteroid, having diabetic and asthma were not include in multivariate analysis because the patients with EC were very few which could lead to a very wide confidence interval.
Characteristics of HIV negative patients with EC
| S/number | Sex | Age | Presentation | Alcohol | Smoking | Antibiotic | Diabetic | Cirrhosis | PUD | Asthma |
| 1 | Male | 20 | Hemoptysis | Yes | Yes | No | No | Yes | No | No |
| 2 | Female | 24 | Ep. pain | No | No | Yes | No | No | Yes | No |
| 3 | Male | 32 | Ep. Pain | Yes | Yes | Yes | No | No | No | No |
| 4 | Female | 30 | Ep. Pain | Yes | No | Yes | No | No | No | No |
| 5 | Male | 47 | Dysphagia | Yes | Yes | Yes | Yes | No | No | No |
| 6 | Female | 17 | Dysphagia | No | No | No | No | No | No | Yes |
| 7 | Male | 40 | Ep. pain | Yes | No | Yes | No | No | Yes | No |
| 8 | Female | 38 | Ep. pain | Yes | No | No | Yes | No | No | No |
| 9 | Female | 47 | Ep. pain | No | No | No | Yes | No | No | No |
| 10 | Male | 77 | Ep. pain | Yes | Yes | Yes | No | No | No | No |
| 11 | Female | 38 | Ep. pain | No | No | Yes | No | No | Yes | No |
| 12 | Male | 34 | UGIB | Yes | Yes | No | No | No | Yes | No |
| 13 | Female | 60 | Ep. pain | Yes | No | Yes | No | No | Yes | No |
| 14 | Male | 28 | Ep. pain | Yes | Yes | No | No | No | No | No |
| 15 | Male | 40 | Dysphagia | Yes | No | No | Yes | No | Yes | No |
| 16 | Male | 36 | Ep. pain | Yes | No | Yes | Yes | No | No | No |
| 17 | Male | 44 | UGIB | Yes | Yes | No | No | Yes | No | No |
| 18 | Female | 62 | Ep. pain | No | No | No | Yes | No | No | No |
| 19 | Female | 33 | Ep. pain | Yes | No | Yes | No | No | Yes | No |
| 20 | Male | 23 | Ep. pain | No | No | Yes | No | No | No | Yes |
Note; Ep. Pain is epigastric pain and UGIB is upper gastro intestinal bleeding